BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27094614)

  • 1. Extramedullary acute myelogenous leukemia.
    Solh M; Solomon S; Morris L; Holland K; Bashey A
    Blood Rev; 2016 Sep; 30(5):333-9. PubMed ID: 27094614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and emerging therapies for acute myeloid leukemia.
    Robak T; Wierzbowska A
    Clin Ther; 2009; 31 Pt 2():2349-70. PubMed ID: 20110045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation: better prognosis than systemic relapse.
    Solh M; DeFor TE; Weisdorf DJ; Kaufman DS
    Biol Blood Marrow Transplant; 2012 Jan; 18(1):106-12. PubMed ID: 21703975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia.
    Ge L; Ye F; Mao X; Chen J; Sun A; Zhu X; Qiu H; Jin Z; Miao M; Fu C; Ma X; Chen F; Xue S; Ruan C; Wu D; Tang X
    Biol Blood Marrow Transplant; 2014 Jul; 20(7):1040-7. PubMed ID: 24704575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimally differentiated acute myelogenous leukemia (AML-M0) granulocytic sarcoma presenting in the oral cavity.
    Amin KS; Ehsan A; McGuff HS; Albright SC
    Oral Oncol; 2002 Jul; 38(5):516-9. PubMed ID: 12110349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of extramedullary leukemia as a presentation of acute myeloid leukemia.
    Slomowitz SJ; Shami PJ
    J Natl Compr Canc Netw; 2012 Sep; 10(9):1165-9. PubMed ID: 22956813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation.
    Stölzel F; Hackmann K; Kuithan F; Mohr B; Füssel M; Oelschlägel U; Thiede C; Röllig C; Platzbecker U; Schetelig J; Illmer T; Schaich M; Seliger B; Hartmann A; Baretton G; Zietz C; Ehninger G; Schrock E; Bornhäuser M
    Transplantation; 2012 Apr; 93(7):744-9. PubMed ID: 22314337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome assessment of age group-specific (+/- 50 years) post-remission consolidation with high-dose cytarabine or bone marrow autograft for adult acute myelogenous leukemia.
    Bassan R; Raimondi R; Lerede T; D'emilio A; Buelli M; Borleri G; Personeni A; Bellavita P; Rodeghiero F; Barbui T
    Haematologica; 1998 Jul; 83(7):627-35. PubMed ID: 9718868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation associated with improved survival?
    Curley C; Durrant S; Kennedy GA
    Asia Pac J Clin Oncol; 2013 Sep; 9(3):285-9. PubMed ID: 23418909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid sarcoma without circulating leukemia mimicking gastrointestinal malignancy and lymphoma.
    Ravulapati S; Siegel C; Dara A; Lionberger JM
    Hematol Rep; 2018 May; 10(2):7040. PubMed ID: 30046410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unrelated donor bone marrow transplantation using a chemotherapy-only preparative regimen for adults with high-risk acute myelogenous leukemia.
    Ayash LJ; Ratanatharathorn V; Braun T; Silver SM; Reynolds CM; Uberti JP
    Am J Hematol; 2007 Jan; 82(1):6-14. PubMed ID: 16986128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia.
    Shimizu H; Saitoh T; Hatsumi N; Takada S; Handa H; Jimbo T; Sakura T; Miyawaki S; Nojima Y
    Leuk Res; 2013 Nov; 37(11):1477-81. PubMed ID: 24054717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.
    Zittoun RA; Mandelli F; Willemze R; de Witte T; Labar B; Resegotti L; Leoni F; Damasio E; Visani G; Papa G
    N Engl J Med; 1995 Jan; 332(4):217-23. PubMed ID: 7808487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission.
    Tallman MS; Pérez WS; Lazarus HM; Gale RP; Maziarz RT; Rowe JM; Marks DI; Cahn JY; Bashey A; Bishop MR; Christiansen N; Frankel SR; García JJ; Ilhan O; Laughlin MJ; Liesveld J; Linker C; Litzow MR; Luger S; McCarthy PL; Milone GA; Pavlovsky S; Phillips GL; Russell JA; Saez RA; Schiller G; Sierra J; Weiner RS; Zander AR; Zhang MJ; Keating A; Weisdorf DJ; Horowitz MM
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):204-16. PubMed ID: 16443518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission.
    Schiller GJ; Nimer SD; Territo MC; Ho WG; Champlin RE; Gajewski JL
    J Clin Oncol; 1992 Jan; 10(1):41-6. PubMed ID: 1727924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and Therapeutic Considerations for Extramedullary Leukemia.
    Bakst R; Powers A; Yahalom J
    Curr Oncol Rep; 2020 Jun; 22(7):75. PubMed ID: 32577912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: an easily overlooked but significant pattern of relapse.
    Yoshihara S; Ando T; Ogawa H
    Biol Blood Marrow Transplant; 2012 Dec; 18(12):1800-7. PubMed ID: 22634018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current status of therapy and prognosis in acute adult leukemia].
    Gmür J
    Ther Umsch; 1996 Feb; 53(2):111-6. PubMed ID: 8629260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.
    Yalman N; Sarper N; Devecioğlu O; Anak S; Eryilmaz E; Can M; Yenilmez H; Ağaoğlu L; Gedikoğlu G
    Turk J Pediatr; 2000; 42(3):198-204. PubMed ID: 11105617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.